The NIEHS Exposure Science and the Exposome Webinar Series
December 9, 2015
The NIEHS Strategic Plan places a significant emphasis on transforming exposure science through the development of new approaches to exposure assessment, the definition and dissemination of the exposome concept, and the development and demonstration of the exposome as a tool for both epidemiological and mechanistic research. In order to achieve this goal, NIEHS launched the Exposure Science and the Exposome Webinar Series on April 4, 2014 to foster discussions on international efforts in advancing exposure science and the exposome concept as well as challenges and opportunities in incorporating this concept in environmental health research (view previous webinars on YouTube).
EXPOsOMICS & HELIX Joint Webinar for Stakeholders
Date: Wednesday, December 9, 2015
Time: 11:00 a.m. - 1:00 p.m. EDT
Will the Exposome Contribute to Risk Assessment?
Interactions with Policy-making Exposomics and Helix are two large “exposome” consortia funded by the European Commission (FP7). The aims of involvement of stakeholders included integrating and disseminating the most relevant results: (a) on the “reduction of uncertainty” paradigm; (b) on the role of multiple environmental contaminants in disease risk, on the basis of improved exposure assessment; (c) on novel chemical risks identified via untargeted omics (“hazard identification”); (d) and on the burden of disease attributable to environmental agents (how the latter changes with improved exposure assessment and risk estimation, for selected exposures and diseases). Helix has a special focus on children.
All these aspects are highly relevant for a number of stakeholders, in particular for policymakers and international agencies including: (a) a refined model for exposure assessment that would have an impact on environmental policies; (b) estimates of reduction of uncertainty and refined estimates of the burden of disease attributable to selected environmental exposures. To this end, a network of stakeholders was identified and encouraged to become actively involved in the project. These included WHO, US EPA, US, NIEHS, EEA, NGOs, industry representatives and others.
We proposed a Webinar on the transfer of exposome science and its result into regulatory decisions. The Webinar was organized into several sessions that involved both scientists active in exposome science and policy-makers.